Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Genus plc ( (GB:GNS) ) has shared an update.
Genus plc has announced the retirement of Professor Jason Chin from its Board of Directors, effective May 2025, as he assumes a new role at the Ellison Institute of Technology. Professor Chin, who has served as a Non-Executive Director and Chairman of the Scientific Advisory Board, will continue as a member of the advisory board. The company has begun searching for his successor, highlighting the importance of his contributions to Genus’s scientific advancements.
More about Genus plc
Genus plc is a world-leading animal genetics company that advances animal breeding and genetic improvement through biotechnology. It provides added value products for livestock farming and food producers, with a focus on dairy, beef, and pork sectors. Genus operates globally, selling products in over seventy-five countries under the ‘ABS’ and ‘PIC’ trademarks, and maintains a competitive edge through proprietary breeding lines and a robust global supply chain.
YTD Price Performance: 16.26%
Average Trading Volume: 128,762
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £1.18B
Learn more about GNS stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue